Le mode conseil est activé Arrêter
Pour la navigation rapide entre les blocs

Organisation: Gamida Cell

Nom de l'organisation
Gamida Cell Ltd.
Nom du pays
Israël
Pays d'enregistrement
Israël
Secteur économique
Production de médicaments et biotechnologies
Dette obligataire
75 millions USD

explorer la base de données la plus complète

800 000

obligations globalement

Plus de 400

sources de prix

80 000

actions

9 000

ETF

suivre votre portefeuille de la manière la plus efficace
screener d'obligations
liste de surveillance
Excel ADD-IN
Obtenir l'accès

Dernières données pour

Cotations

Requête envoyé
Accès refusé
Envoyer la requête
Les cotations fournis par les fournisseurs d’information sont de nature indicative

Profile

Gamida Cell Ltd., a clinical stage biopharmaceutical company, focuses on developing cell therapies to cure cancer, and rare and serious hematologic diseases in the United States, the European Union, and internationally.

Récompenses

Actualités

22/04/2024 Gamida Cell: Bankruptcy Or Receivership
26/03/2024 Gamida Cell: Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard; Transfer Of Listing, Other Events, Financial Statements And Exhibits
26/03/2024 Gamida Cell: Entry Into A Material Definitive Agreement, Results Of Operations And Financial Condition, Triggering Events That Accelerate Or Increase A Direct Financial Obligation Or An Obligation Under An Offbalance Sheet Arrangement, Costs Associated With Exit Or Disposal Activities, Departure Of Directors Or Principal Officers; Election Of Directors; Appointment Of Principal Officers, Other Events, Financial Statements And Exhibits
26/03/2024 Gamida Cell: Other Events, Financial Statements And Exhibits
12/03/2024 Gamida Cell: Departure Of Directors Or Certain Officers; Election Of Directors; Appointment Of Certain Officers; Compensatory Arrangements Of Certain Officers
Toutes les actualités de l'organisation

Documents

Etats financiers IFRS / US GAAP

2023
I q ang
II q ang
III q ang
IV q ang
2022
I q ang
II q ang
III q ang
IV q ang
2021
IV q ang
2020
IV q ang
2019
IV q ang
2018
IV q ang
Afficher tout Masquer
Il faut s'enregistrer
Envoyer la demande d'accès accès

Actions

Dernières émissions

Montrer tout

Dette obligataire par devise

Montrer tout Cacher

Codes

  • SIC
    2836 BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
  • CIK
    0001600847

Notations de crédit et notations d’ESG

Macroéconomie

Vous devez vous inscrire pour y accéder.